“Assessing Long-Term Maintenance of Efficacy With Tralokinumab Monotherapy in Patients With Moderate-to-Severe Atopic Dermatitis: Combined Results from Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials (ECZTRA 1 and 2)”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s57. Accessed April 16, 2025. https://skin.dermsquared.com/skin/article/view/1408.